Modulation of Ang-2 to Treat Pathologic Lymphangiogenesis
Local or systemic administrationDemonstrated in mouse modelDemonstrated in human in vitro culture system
Corneal vascularization in various diseasesCorneal transplants in low-risk and high-risk settingsOther tissue or organ transplantOther immune- or lymphatic-related disorders, such as cancer metastasis
None
Related Materials "Role of Ang-2 in Corneal Lymphangiogenesis" in Investigative Ophthalmology & Visual Science Additional Technologies by these Inventors Tech ID/UC Case 22347/2012-101-0 Related Cases 2012-101-0, 2012-097-0, 2012-012-0
USA

